Raras
Buscar doenças, sintomas, genes...
Epilepsia mioclônica juvenil
ORPHA:307CID-10 · G40.3CID-11 · 8A61.30OMIM 254770PCDT · SUSDOENÇA RARA

A síndrome de epilepsia generalizada idiopática hereditária mais comum é caracterizada por espasmos mioclônicos dos membros superiores ao acordar, convulsões tônico-clônicas generalizadas que se manifestam durante a adolescência e são desencadeadas por privação de sono, ingestão de álcool e atividades cognitivas, e crises de ausência típicas (30% dos casos).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome de epilepsia generalizada idiopática hereditária mais comum é caracterizada por espasmos mioclônicos dos membros superiores ao acordar, convulsões tônico-clônicas generalizadas que se manifestam durante a adolescência e são desencadeadas por privação de sono, ingestão de álcool e atividades cognitivas, e crises de ausência típicas (30% dos casos).

Pesquisas ativas
1 ensaio
4 total registrados no ClinicalTrials.gov
Publicações científicas
1.460 artigos
Último publicado: 2026 Apr 8

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adolescent
+ childhood
🏥
SUS: Cobertura parcialScore: 45%
PCDT disponívelCID-10: G40.3
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
26 sintomas
👁️
Olhos
6 sintomas
🦴
Ossos e articulações
3 sintomas
💪
Músculos
2 sintomas
😀
Face
1 sintomas
👂
Ouvidos
1 sintomas

+ 19 sintomas em outras categorias

Características mais comuns

90%prev.
Miotonia matinal
Muito frequente (99-80%)
90%prev.
EEG com complexos de poliespícula e onda
Muito frequente (99-80%)
90%prev.
Crise de início generalizado
Muito frequente (99-80%)
77%prev.
Crise mioclônica
Frequência: 10/13
61%prev.
Crise não motora (ausência) generalizada
Ocasional (29-5%)
57%prev.
Crise tônico-clônica bilateral
Frequência: 13/23
60sintomas
Muito frequente (3)
Frequente (5)
Ocasional (2)
Muito raro (3)
Sem dados (47)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 60 características clínicas mais associadas, ordenadas por frequência.

Miotonia matinalMorning myoclonic jerks
Muito frequente (99-80%)90%
EEG com complexos de poliespícula e ondaEEG with polyspike wave complexes
Muito frequente (99-80%)90%
Crise de início generalizadoGeneralized-onset seizure
Muito frequente (99-80%)90%
Crise mioclônicaMyoclonic seizure
Frequência: 10/1377%
Crise não motora (ausência) generalizadaGeneralized non-motor (absence) seizure
Ocasional (29-5%)61%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.460PubMed
Últimos 10 anos200publicações
Pico202459 papers
Linha do tempo
2026Hoje · 2026🧪 2011Primeiro ensaio clínico📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

9 genes identificados com associação a esta condição. Padrão de herança: Multigenic/multifactorial.

EFHC1EF-hand domain-containing protein 1Major susceptibility factor inTolerante
FUNÇÃO

Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating (PubMed:36191189). Microtubule-associated protein which regulates cell division and neuronal migration during cortical development (PubMed:19734894, PubMed:28370826). Necessary for radial and tangential cell migration during brain development, possibly acting as a regulator of cell morphology and process formation during migration (PubMed:22926142)

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium axonemeCytoplasm, cytoskeleton, flagellum axonemeCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, spindle pole

MECANISMO DE DOENÇA

Juvenile myoclonic epilepsy 1

A subtype of idiopathic generalized epilepsy. Patients have afebrile seizures only, with onset in adolescence (rather than in childhood) and myoclonic jerks which usually occur after awakening and are triggered by sleep deprivation and fatigue.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
17.6 TPM
Tireoide
13.0 TPM
Testículo
12.7 TPM
Cervix Endocervix
11.6 TPM
Fallopian Tube
10.2 TPM
OUTRAS DOENÇAS (3)
juvenile absence epilepsyjuvenile myoclonic epilepsyepilepsy, juvenile absence, susceptibility to, 1
HGNC:16406UniProt:Q5JVL4
CLN8Protein CLN8Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Could play a role in cell proliferation during neuronal differentiation and in protection against cell death

LOCALIZAÇÃO

Endoplasmic reticulum membraneEndoplasmic reticulum-Golgi intermediate compartment membraneEndoplasmic reticulum

MECANISMO DE DOENÇA

Ceroid lipofuscinosis, neuronal, 8

A form of neuronal ceroid lipofuscinosis with onset in childhood. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment patterns observed most often in neuronal ceroid lipofuscinosis type 8 comprise mixed combinations of granular, curvilinear, and fingerprint profiles.

OUTRAS DOENÇAS (2)
neuronal ceroid lipofuscinosis 8neuronal ceroid lipofuscinosis 8 northern epilepsy variant
HGNC:2079UniProt:Q9UBY8
GABRDGamma-aminobutyric acid receptor subunit deltaMajor susceptibility factor inTolerante
FUNÇÃO

Delta subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:35355020). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:35355020). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Generalized epilepsy with febrile seizures plus 5

A rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
538.4 TPM
Cerebelo
517.0 TPM
Brain Frontal Cortex BA9
104.9 TPM
Córtex cerebral
95.3 TPM
Brain Nucleus accumbens basal ganglia
54.4 TPM
OUTRAS DOENÇAS (4)
chromosome 1p36 deletion syndromegeneralized epilepsy with febrile seizures plusjuvenile myoclonic epilepsyepilepsy, idiopathic generalized, susceptibility to, 10
HGNC:4084UniProt:O14764
JRKJerky protein homologCandidate gene tested inDesconhecido
FUNÇÃO

May bind DNA

LOCALIZAÇÃO

Nucleus

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
14.4 TPM
Fibroblastos
13.5 TPM
Cérebro - Hemisfério cerebelar
13.4 TPM
Ovário
12.3 TPM
Linfócitos
11.4 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
childhood absence epilepsyjuvenile myoclonic epilepsy
HGNC:6199UniProt:O75564
KCNQ3Potassium voltage-gated channel subfamily KQT member 3Major susceptibility factor inAltamente restrito
FUNÇÃO

Pore-forming subunit of the voltage-gated potassium (Kv) M-channel which is responsible for the M-current, a key controller of neuronal excitability (PubMed:16319223, PubMed:27564677, PubMed:28793216, PubMed:9872318). M-channel is composed of pore-forming subunits KCNQ2 and KCNQ3 assembled as heterotetramers (PubMed:14534157, PubMed:16319223, PubMed:27564677, PubMed:9872318). The native M-current has a slowly activating and deactivating potassium conductance which plays a critical role in determ

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsVoltage gated Potassium channels
MECANISMO DE DOENÇA

Seizures, benign familial neonatal 2

A disorder characterized by clusters of seizures occurring in the first days of life. Most patients have spontaneous remission by 12 months of age and show normal psychomotor development. The disorder is distinguished from benign familial infantile seizures by an earlier age at onset.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
22.6 TPM
Córtex cerebral
18.2 TPM
Brain Anterior cingulate cortex BA24
17.4 TPM
Brain Nucleus accumbens basal ganglia
15.7 TPM
Brain Caudate basal ganglia
11.6 TPM
OUTRAS DOENÇAS (4)
seizures, benign familial neonatal, 2benign neonatal seizuresbenign familial infantile epilepsyjuvenile myoclonic epilepsy
HGNC:6297UniProt:O43525
GABRA1Gamma-aminobutyric acid receptor subunit alpha-1Major susceptibility factor inAltamente restrito
FUNÇÃO

Alpha subunit of the heteropentameric ligand-gated chloride channel gated by Gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:23909897, PubMed:25489750, PubMed:29950725, PubMed:30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:29950725, PubMed:30602789). When activated by GA

LOCALIZAÇÃO

Postsynaptic cell membraneCell membraneCytoplasmic vesicle membrane

VIAS BIOLÓGICAS (2)
GABA receptor activationSignaling by ERBB4
MECANISMO DE DOENÇA

Epilepsy, childhood absence 4

A subtype of idiopathic generalized epilepsy characterized by an onset at age 6-7 years, frequent absence seizures (several per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Tonic-clonic seizures often develop in adolescence. Absence seizures may either remit or persist into adulthood.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
82.7 TPM
Brain Frontal Cortex BA9
58.5 TPM
Cerebelo
55.7 TPM
Córtex cerebral
31.1 TPM
Brain Anterior cingulate cortex BA24
23.3 TPM
OUTRAS DOENÇAS (5)
developmental and epileptic encephalopathy, 19obsolete Dravet syndromechildhood absence epilepsyjuvenile myoclonic epilepsy
HGNC:4075UniProt:P14867
CILK1Serine/threonine-protein kinase ICKMajor susceptibility factor inTolerante
FUNÇÃO

Required for ciliogenesis (PubMed:24797473). Phosphorylates KIF3A (By similarity). Involved in the control of ciliary length (PubMed:24853502). Regulates the ciliary localization of SHH pathway components as well as the localization of IFT components at ciliary tips (By similarity). May play a key role in the development of multiple organ systems and particularly in cardiac development (By similarity). Regulates intraflagellar transport (IFT) speed and negatively regulates cilium length in a cAM

LOCALIZAÇÃO

NucleusCytoplasm, cytosolCell projection, ciliumCytoplasm, cytoskeleton, cilium basal bodyCytoplasm

MECANISMO DE DOENÇA

Endocrine-cerebroosteodysplasia

Previously unidentified neonatal lethal recessive disorder with multiple anomalies involving the endocrine, cerebral, and skeletal systems.

OUTRAS DOENÇAS (3)
endocrine-cerebro-osteodysplasia syndromejuvenile myoclonic epilepsyepilepsy, juvenile myoclonic, susceptibility to, 10
HGNC:21219UniProt:Q9UPZ9
CACNB4Voltage-dependent L-type calcium channel subunit beta-4Major susceptibility factor inTolerante
FUNÇÃO

The beta subunit of voltage-dependent calcium channels contributes to the function of the calcium channel by increasing peak calcium current, shifting the voltage dependencies of activation and inactivation, modulating G protein inhibition and controlling the alpha-1 subunit membrane targeting

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Presynaptic depolarization and calcium channel opening
MECANISMO DE DOENÇA

Epilepsy, idiopathic generalized 9

A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain.

OUTRAS DOENÇAS (3)
episodic ataxia type 5juvenile myoclonic epilepsyepilepsy, idiopathic generalized, susceptibility to, 9
HGNC:1404UniProt:O00305
CLCN2Chloride channel protein 2Major susceptibility factor inTolerante
FUNÇÃO

Voltage-gated and osmosensitive chloride channel. Forms a homodimeric channel where each subunit has its own ion conduction pathway. Conducts double-barreled currents controlled by two types of gates, two fast glutamate gates that control each subunit independently and a slow common gate that opens and shuts off both subunits simultaneously. Displays inward rectification currents activated upon membrane hyperpolarization and extracellular hypotonicity (PubMed:16155254, PubMed:17567819, PubMed:19

LOCALIZAÇÃO

Cell membraneBasolateral cell membraneCell projection, dendritic spine membraneCell projection, axon

VIAS BIOLÓGICAS (1)
Stimuli-sensing channels
MECANISMO DE DOENÇA

Epilepsy, idiopathic generalized 11

A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain.

VIAS REACTOME (1)
OUTRAS DOENÇAS (4)
leukoencephalopathy with mild cerebellar ataxia and white matter edemafamilial hyperaldosteronism type IIjuvenile myoclonic epilepsyepilepsy, idiopathic generalized, susceptibility to, 11
HGNC:2020UniProt:P51788

Medicamentos aprovados (FDA)

1 medicamento encontrado nos registros da FDA americana.

💊 Levetiracetam (LEVETIRACETAM)
Ver no DailyMed/FDA

Variantes genéticas (ClinVar)

505 variantes patogênicas registradas no ClinVar.

🧬 EFHC1: NM_018100.4(EFHC1):c.573+145T>A ()
🧬 EFHC1: NM_018100.4(EFHC1):c.64-260G>T ()
🧬 EFHC1: NM_018100.4(EFHC1):c.64-261A>T ()
🧬 EFHC1: NM_018100.4(EFHC1):c.917-1G>C ()
🧬 EFHC1: GRCh37/hg19 6p12.3-12.1(chr6:50181657-55538355)x1 ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 22
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 3 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Epilepsia mioclônica juvenil

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

4 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
589 papers (10 anos)
#1

Investigation of adolescent cases diagnosed with idiopathic/genetic generalized epilepsy in terms of self-esteem, aggression, body perception, and alexithymia.

European journal of pediatrics2026 Mar 19

This study examined self-esteem, body image, alexithymia, and aggression in adolescents with idiopathic/genetic generalized epilepsy (IGE). These domains were selected because they may be affected not only by epilepsy itself but also by stigma, difficulties in emotional regulation, or treatment-related effects. Assessing these domains together was intended to examine whether IGE might be associated with additional psychosocial strain in otherwise clinically stable adolescents. We carried out a case-control study including 45 adolescents with IGE and 45 controls matched for age and sex. Controls were selected from outpatient services and were required to have no neurological disorders. Psychiatric disorders were assessed using the K-SADS (Kiddie Schedule for Affective Disorders and Schizophrenia) interview; no clinically significant psychiatric diagnoses were identified in the control group. All participants completed standardized Turkish questionnaires on the same day.Within the epilepsy group, 20.0% were diagnosed with juvenile absence epilepsy (JAE), 22.2% with juvenile myoclonic epilepsy (JME), and 57.8% with epilepsy with generalized tonic-clonic seizures alone (EGTCSA). Across all four psychological measures, the epilepsy and control groups showed no statistically significant differences (all p > 0.05). No significant differences were found in subgroup analyses based on epilepsy syndrome or seizure frequency. Adolescents with well-controlled IGE and minimal psychiatric comorbidities demonstrated comparable levels of psychosocial functioning to their healthy peers. This finding is consistent with evidence suggesting that psychosocial difficulties in epilepsy are often linked to comorbidity and contextual factors rather than to the diagnosis alone. Studies conducted in broader settings and with larger, more varied samples will be needed to better understand how medical, emotional, and environmental factors jointly influence psychosocial outcomes in this population. • Adolescents with epilepsy are frequently considered at increased risk for psychosocial difficulties, including lower self-esteem, emotional instability, and body image concerns. • In this study, no significant differences were found in self-esteem, body image, alexithymia, or aggression among Turkish adolescents with idiopathic/genetic generalized epilepsy compared with healthy controls. These findings suggest that, when seizures are well controlled and psychiatric comorbidities are limited, epilepsy itself may not confer additional psychosocial vulnerability.

#2

Transcriptional and neurotransmitter signatures associated with regional gray matter alterations in juvenile myoclonic epilepsy.

Frontiers in molecular neuroscience2026

The neurobiological basis of gray matter (GM) alterations in juvenile myoclonic epilepsy (JME) remains poorly understood. This study aimed to identify robust GM changes and their underlying molecular signatures. We performed an updated coordinate-based meta-analysis of 15 voxel-based morphometry studies (394 JME patients, 448 healthy controls) and integrated the resulting GM alteration map with data from the Allen Human Brain Atlas and neurotransmitter atlases using advanced spatial correlation, gene enrichment, and network analysis approaches. Our analysis revealed a consistent pattern of GM decreases in the sensorimotor areas and increases in regions implicated in emotion and cognition. These structural changes were spatially correlated with a set of 926 genes enriched for pathways related to ion channel activity, synaptic function, neuronal processes, and cellular metabolism, which showed peak expression during neurodevelopmental periods coinciding with JME onset. Protein-protein interaction analysis identified hub genes from two key functional classes: transcriptional regulators linked to circadian rhythms, and cellular signaling molecules including established monogenic epilepsy genes. Furthermore, the GM map correlated significantly with the spatial distributions of the serotonin, dopamine, and acetylcholine neurotransmitter systems. While these associations are based on data from healthy donors and require further validation, our findings bridge the gap between macroscopic brain alterations and their underlying molecular architecture in JME. This provides an integrated model of its pathophysiology and highlights potential therapeutic avenues.

#3

Exploring Balance and Functional Mobility in Children with Juvenile Myoclonic Epilepsy, Effects of Cognitive and Motor Dual-Tasks: An Exploratory Pilot Study.

Physical &amp; occupational therapy in pediatrics2026

This pilot study aimed to assess the dual-task performance and balance ability in children and adolescents with Juvenile Myoclonic Epilepsy (JME). Additionally, it sought to investigate the impact of dual-task conditions on functional performance and explore relationship between balance ability and dual-task performance. Ten children and adolescents with JME (mean age 16.90 ± 1.20 years) were evaluated. Static and dynamic balance were assessed using the Balance Master System, with modified Clinical Test of Sensory Interaction on Balance (mCTSIB) and Limit of Stability tests measuring static and dynamic balance, respectively. The mCTSIB and TUG tests were performed under single- and dual-task (motor-motor, cognitive-motor) conditions. No significant differences were found in mCTSIB test between single-task and dual-task conditions (p > 0.05). However, TUG completion time increased under cognitive-motor dual-task conditions (p < 0.05). There was no significant correlation between balance and dual-task performance (p > 0.05). This exploratory pilot study, conducted without a control group, suggests that children with JME may face difficulties with tasks requiring both cognitive and motor functions, as cognitive-motor dual tasks significantly increased task completion time. Lower scores in certain balance measures suggest a potential risk of balance impairment. These findings underscore the importance of integrating both cognitive-motor dual-task and balance assessments into rehabilitation programs for children with JME.

#4

Effects of lipid-lowering drugs on epilepsy and its subtypes: A drug-target Mendelian randomization study.

Medicine2026 Mar 20

Statins, commonly used lipid-lowering drugs to reduce cardiovascular risk, have also been suggested to have protective effects against epilepsy. However, whether this association is causal remains unclear. We conducted a drug-target Mendelian randomization study to examine the effects of genetically predicted inhibition of 3 established lipid-lowering targets (3-hydroxy-3-methylglutaryl coenzyme A reductase [statins], Niemann-Pick C1-Like 1 [ezetimibe], and proprotein convertase subtilisin/kexin type 9 [PCSK9 inhibitors]) on epilepsy and its subtypes. The inverse-variance weighted approach served as the primary analysis, supplemented with multiple sensitivity tests to ensure robustness. Genetically proxied 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition was associated with decreased risks of epilepsy (odds ratio [OR] = 0.87; 95% confidence interval [CI]: 0.82-0.92; P = 1.4 × 10-6) and focal epilepsy (OR = 0.83; 95% CI: 0.76-0.92; P = 1.5 × 10-4). Inhibition of Niemann-Pick C1-Like 1 corresponded to a lower risk of generalized epilepsy with tonic-clonic seizures (OR = 0.98; 95% CI: 0.97-0.98; P = 1.2 × 10-34) but increased risks of focal epilepsy (lesion negative, OR = 1.08; 95% CI: 1.06-1.09; P = 5.9 × 10-31), childhood absence epilepsy (OR = 1.06; 95% CI: 1.05-1.07; P = 1.8 × 10-21), and juvenile absence epilepsy (OR = 1.03; 95% CI: 1.01-1.05; P = 9.7 × 10-3). PCSK9 inhibition was linked to reduced risks of generalized epilepsy with tonic-clonic seizures (OR = 0.99; 95% CI: 0.98-1.00; P = 1.4 × 10-2), juvenile absence epilepsy (OR = 0.96; 95% CI: 0.93-1.00; P = 2.7 × 10-2), and juvenile myoclonic epilepsy (OR = 0.96; 95% CI: 0.93-1.00; P = 2.9 × 10-2). The effects of lipid-lowering drug targets on epilepsy risk vary by target and exhibit pleiotropy. Statins and PCSK9 inhibitors appear protective against epilepsy and several subtypes, whereas ezetimibe may increase susceptibility to certain subtypes. These results underscore the importance of considering target-specific effects when choosing lipid-lowering therapies for patients with or at risk of epilepsy.

#5

Sleep disorders in patients with juvenile myoclonic epilepsy: A polysomnographic investigation.

Epilepsy research2026 Feb 11

Juvenile myoclonic epilepsy (JME) is an idiopathic generalized epilepsy precipitated by sleep deprivation and display a circadian distribution. This study aimed to determine the frequency of sleep disorders (insomnia, snorring, sleep apnea, restless leg syndrome, bruxism, hipersomnia) and sleep architecture in JME, to evaluate associations with seizure variables and antiseizure medications, and to investigate polysomnographic parameters. Forty adults with JME and thirty healthy controls underwent overnight laboratory-based polysomnography. Participants completed the Beck Depression Inventory (BDI), Pittsburgh Sleep Quality Index (PSQI), and Epworth Sleepiness Scale (ESS). Insomnia and restless legs syndrome (RLS) were assessed according to ICSD-3 criteria. Sleep architecture, respiratory indices and periodic limb movements were analyzed. Patients on valproate(VPA) were compared with those on levetiracetam. Correlations between epilepsy duration, seizure frequency, and sleep parameters were also examined. JME patients showed significantly prolonged sleep latencies to N1, N2 stages. Minimum nocturnal oxygen saturation was lower, OSAS(obstructive sleep apnea syndrome), snoring were more frequent in JME group. Longer epilepsy duration correlated with poorer sleep efficiency, shorter total sleep time, and reduced N3 sleep, as well as increased wake after sleep onset. VPA was associated with higher BMI, higher AHI(Apnea hypopnea index) and ODI(oxygen desaturation index), lower minimum oxygen saturation, and lower QoLIE-31 "seizure worry" subscores. JME is characterized by prolonged NREM stage latencies, increased snoring, OSA and lower oxygen saturation. VPA therapy was associated with more severe respiratory disturbance, likely related to weight gain. Sleep disorders should routinely be screened for and appropriately managed in patients with JME, and antiepileptic treatment choices should be made with these factors in mind.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC773 artigos no totalmostrando 195

2026

Effects of lipid-lowering drugs on epilepsy and its subtypes: A drug-target Mendelian randomization study.

Medicine
2026

Investigation of adolescent cases diagnosed with idiopathic/genetic generalized epilepsy in terms of self-esteem, aggression, body perception, and alexithymia.

European journal of pediatrics
2026

Sleep disorders in patients with juvenile myoclonic epilepsy: A polysomnographic investigation.

Epilepsy research
2026

Transcriptional and neurotransmitter signatures associated with regional gray matter alterations in juvenile myoclonic epilepsy.

Frontiers in molecular neuroscience
2026

Relevance of EEG recording time for juvenile myoclonic epilepsy diagnosis confirmation: a reappraisal.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2026

Syndrome-specific and familial imaging traits in juvenile absence epilepsy.

Epilepsia
2026

White matter structure-function decoupling in juvenile myoclonic epilepsy.

NeuroImage. Clinical
2026

Effective connectivity of face and fear processing in juvenile myoclonic epilepsy.

Epilepsy &amp; behavior : E&amp;B
2026

Bidirectional causal relationships between epilepsy subtypes and psychiatric disorders: A two-sample mendelian randomization study.

Journal of affective disorders
2026

Epilepsy and stroke: A mendelian Randomization study.

Epilepsy research
2026

Theory of mind in juvenile myoclonic epilepsy.

Epilepsia
2025

Case Report: Electroacupuncture combined with transcutaneous auricular vagus nerve stimulation for treating antiseizure medication-resistant juvenile myoclonic epilepsy.

Frontiers in psychiatry
2026

Seizure freedom in pediatric juvenile myoclonic epilepsy: The roles of cognition, chronodependency, and EEG.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
2025

Personality disorders in idiopathic generalized epilepsies in adults.

Journal of neurology
2025

Juvenile Myoclonic Epilepsy in Children and Adolescents: The Effect of Antiseizure Medications on Cognitive Functions.

Journal of child neurology
2025

Altered resting-state functional connectivity in the sleep-wake circuit in juvenile myoclonic epilepsy: A Seed-based fMRI study.

Epilepsy &amp; behavior : E&amp;B
2025

Using Cenobamate for managing idiopathic generalized epilepsy: A single-center experience and systematic literature review.

Epilepsia open
2025

Clinical and Electrophysiological Characteristics and Prognosis of Childhood Occipital Visual Epilepsy in Light of Current ILAE Criteria.

Clinical EEG and neuroscience
2026

Exploring Balance and Functional Mobility in Children with Juvenile Myoclonic Epilepsy, Effects of Cognitive and Motor Dual-Tasks: An Exploratory Pilot Study.

Physical &amp; occupational therapy in pediatrics
2025

Increased volumes of the precuneus and the pallidum in idiopathic generalized epilepsy.

Scientific reports
2025

The Many Faces of Juvenile Myoclonic Epilepsy.

Epilepsy currents
2025

General mental ability (Spearman's g) in Juvenile Myoclonic Epilepsy.

Epilepsia open
2025

Enhanced response inhibition in patients with drug-resistant juvenile myoclonic epilepsy: Event-related potentials evidence of excitatory-inhibitory imbalance.

Epilepsia open
2025

Voxel-based meta-analysis of gray matter abnormalities in idiopathic generalized epilepsy.

Cerebral cortex (New York, N.Y. : 1991)
2025

Familial adult myoclonus epilepsy: A comprehensive diagnostic strategy for clinical practice.

Epilepsia
2025

Causal Relationship Between Epilepsy, Status Epilepticus and Sleep-Related Traits: A Bidirectional Mendelian Randomization Study.

Brain sciences
2025

Functional connectivity network based on scalp electroencephalogram in juvenile myoclonic epilepsy.

Seizure
2025

Motor-associated thalamic nuclei are reduced in juvenile myoclonic epilepsy.

Epilepsia
2025

Evidence of Sex-Related Pharmacodynamic Differences in Photosensitive Epilepsy Treated with Valproate: Findings from a Retrospective, Observational, Single-Center, Within-Patient, Cohort Study.

Drugs - real world outcomes
2025

Focus on epilepsy and epilepsy syndromes in children with autism spectrum disorders: a study of 74 patients.

Brain &amp; development
2025

A possible role of Apolipoprotein E in Idiopathic Generalized Epilepsy.

Epilepsy &amp; behavior : E&amp;B
2025

Genome-Wide Insights and Polygenic Risk Scores in Common Epilepsies: A Narrative Review.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2025

Connectomes in Temporal Lobe and Idiopathic Generalized Epilepsies.

Journal of clinical medicine
2025

Juvenile Myoclonic Epilepsy Adventure: A Retrospective Study.

Acta neurologica Taiwanica
2025

Levetiracetam for myoclonic seizures in idiopathic generalized epilepsy: A systematic review and meta-analysis.

Epilepsy &amp; behavior : E&amp;B
2025

Topographic differences in EEG microstates: distinguishing juvenile myoclonic epilepsy from frontal lobe epilepsy.

Cognitive neurodynamics
2025

Juvenile Myoclonic Epilepsy Imaging Endophenotypes and Relationship With Cognition and Resting-State EEG.

Human brain mapping
2025

Analysis of brain network effective connectivity in juvenile myoclonic epilepsy.

Cognitive neurodynamics
2025

A diagnosis and prediction algorithm for juvenile myoclonic epilepsy based on clinical and quantitative EEG features.

Seizure
2025

Subcortical gray matter changes in juvenile myoclonic epilepsy: a volBrain study.

Folia morphologica
2025

Autobiographical memory impairment in genetic generalized epilepsies: neurocognitive and pathophysiological determinants.

Arquivos de neuro-psiquiatria
2025

Long-term outcomes of treatment with levetiracetam and valproate in idiopathic generalized epilepsy.

Seizure
2025

The causal relationship between systemic lupus erythematosus and juvenile myoclonic epilepsy: A Mendelian randomization study and mediation analysis.

Ibrain
2025

Study of Eye Movements Abnormalities in Epilepsy.

Neuro-ophthalmology (Aeolus Press)
2025

Successful seizure control with cenobamate in juvenile myoclonic epilepsy.

Epileptic disorders : international epilepsy journal with videotape
2025

Clarithromycin-induced myoclonic status epilepticus.

Practical neurology
2025

Cognitive and brain health in juvenile myoclonic epilepsy: Role of social determinants of health.

Epilepsia
2025

Clinical Chronobiology: Circadian Rhythms in Health and Disease.

Seminars in neurology
2025

The network neuropsychology of juvenile myoclonic epilepsy.

Cortex; a journal devoted to the study of the nervous system and behavior
2025

Women With Genetic Epilepsies.

Neurology. Genetics
2025

Association of valproate use and hippocampal atrophy in idiopathic generalized epilepsy.

NeuroImage. Clinical
2025

What's the bug?: An unusual cause of bacterial meningitis in a patient with history of transsphenoidal surgery.

The American journal of emergency medicine
2025

Circulating microRNAs as Biomarkers of Various Forms of Epilepsy.

Medical sciences (Basel, Switzerland)
2025

Tremor as an intrinsic feature of juvenile myoclonic epilepsy.

Epilepsia
2025

Reconstruction and application of multilayer brain network for juvenile myoclonic epilepsy based on link prediction.

Cognitive neurodynamics
2024

Power Spectral Density and Default Mode Network Connectivity in Generalized Epilepsy Syndromes: What to Expect from Drug-Resistant Patients.

Biomedicines
2025

Management and outcomes among older adults with generalized epilepsy in routine clinical practice.

Epilepsia open
2025

Unsupervised clustering of a deeply phenotyped cohort of adults with idiopathic generalized epilepsy.

Epilepsia
2024

Generalized Epileptic Seizures in Fibrodysplasia Ossificans Progressiva Harboring a Recurrent Heterozygous Variant of the ACVR1 Gene (R206H).

Case reports in genetics
2024

Causal Relationships Between Epilepsy, Anti-Epileptic Drugs, and Serum Vitamin D and Vitamin D Binding Protein: A Bidirectional and Drug Target Mendelian Randomization Study.

CNS neuroscience &amp; therapeutics
2025

Evidence of small vessel disease in patients with juvenile myoclonic epilepsy based on the peak width of skeletonized mean diffusivity.

Seizure
2025

Assessing the Need for Repeat EEG in Pediatric Patients with Idiopathic Generalized Epilepsy After Anti-Seizure Medication Withdrawal Following Seizure Freedom.

Journal of child neurology
2025

Effects of anti-seizure medications on resting-state functional networks in juvenile myoclonic epilepsy: An EEG microstate analysis.

Seizure
2025

Did Joseph Conrad have juvenile myoclonic epilepsy?

Epilepsia
2025

Whole exome sequencing revealed ultra-rare genetic variations in juvenile myoclonic epilepsy.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Trends in antiseizure medication prescription in Idiopathic generalized epilepsy over the last 10 years.

Epilepsy &amp; behavior : E&amp;B
2024

Genetic heterogeneity in familial forms of genetic generalized epilepsy: from mono- to oligogenism.

Human genomics
2024

Emotional Blind Spots in Juvenile Myoclonic Epilepsy.

Epilepsy currents
2024

Comparative analysis of processing speed impairments in TLE, FLE, and GGE: Theoretical insights and clinical Implications.

Epilepsy &amp; behavior reports
2024

Causal relationships between epilepsy and the microstructure of the white matter: A Mendelian randomization study.

Medicine
2025

Latent cognitive phenotypes in juvenile myoclonic epilepsy: Clinical, sociodemographic, and neuroimaging associations.

Epilepsia
2024

Associations between neurolinguistic deficits and personality traits in people with epilepsy.

Frontiers in neurology
2024

Restricted Cortical Activity Involving Parietal Lobe and Sublobar Region Leads to Generalized Spike-Wave Discharges of Juvenile Myoclonic Epilepsy: Evidence from an EEG Source Localization Study.

Neurology India
2024

Quality of Life, Its Determinants, and Psychiatric Comorbidities in Juvenile Myoclonic Epilepsy: A Cross-Sectional Observational Study From North India.

Cureus
2024

Unraveling the shared genetics of common epilepsies and general cognitive ability.

Seizure
2024

Generalized spike-waves in idiopathic generalized epilepsies: Does their frequency matter?

Brain and behavior
2024

Quantitative MRI Measures and Cognitive Function in People With Drug-Resistant Juvenile Myoclonic Epilepsy.

Neurology
2024

Development and Validation of Artificial Intelligence Models for Prognosis Prediction of Juvenile Myoclonic Epilepsy with Clinical and Radiological Features.

Journal of clinical medicine
2024

Epilepsy associated with Graves' disease: Report of two cases.

SAGE open medical case reports
2024

Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis.

Epilepsia
2024

An Epilepsy-Associated CILK1 Variant Compromises KATNIP Regulation and Impairs Primary Cilia and Hedgehog Signaling.

Cells
2024

Altered effective connectivity of the default mode network in juvenile myoclonic epilepsy.

Cognitive neurodynamics
2024

Causal links between serum micronutrients and epilepsy: a Mendelian randomization analysis.

Frontiers in neurology
2024

The epileptic blip syndrome.

Epilepsy &amp; behavior reports
2024

Sodium valproate is associated with cortical thinning of disease-specific areas in juvenile myoclonic epilepsy.

Journal of neurology, neurosurgery, and psychiatry
2024

A complex case with generalized epilepsy, probable focal seizures, and functional seizures.

Epilepsy &amp; behavior reports
2024

Sleep in juvenile myoclonic epilepsy: A systematic review.

Seizure
2024

Altered dynamic functional connectivity of motor cerebellum with sensorimotor network and default mode network in juvenile myoclonic epilepsy.

Frontiers in neurology
2024

Multilayer network analysis in patients with juvenile myoclonic epilepsy.

Neuroradiology
2024

Assessing the impact of circulating inflammatory cytokines and proteins as drivers and therapeutic targets in epilepsy: A Mendelian randomization study.

Epilepsy &amp; behavior : E&amp;B
2024

Dissecting the Shared Genetic Architecture of Common Epilepsies With Cortical Brain Morphology.

Neurology. Genetics
2024

Correlation Analysis of Multi-Scale Ictal EEG Signals in Juvenile Myoclonic Epilepsy.

Journal of integrative neuroscience
2024

Personality disorders in people with epilepsy: a review.

Frontiers in psychiatry
2024

Brain functional network changes in patients with juvenile myoclonic epilepsy: a study based on graph theory and Granger causality analysis.

Frontiers in neuroscience
2024

Deep brain stimulation of the subthalamic nucleus for a patient with drug resistant juvenile myoclonic epilepsy: 1 year follow-up.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

Alterations in spatiotemporal characteristics of dynamic networks in juvenile myoclonic epilepsy.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

The co-activation patterns of multiple brain regions in Juvenile Myoclonic Epilepsy.

Cognitive neurodynamics
2024

AARS and CACNA1A mutations: diagnostic insights into a case report of uncommon epileptic encephalopathy phenotypes in two siblings.

Frontiers in neurology
2024

Transcranial brain parenchyma sonography in patients with juvenile myoclonic epilepsy.

Acta neurologica Belgica
2024

A systematic review and meta-analysis of factors related to first line drugs refractoriness in patients with juvenile myoclonic epilepsy (JME).

PloS one
2024

Transcranial electrical stimulation during functional magnetic resonance imaging in patients with genetic generalized epilepsy: a pilot and feasibility study.

Frontiers in neuroscience
2024

Idiopathic generalized epilepsy in a family with SCN4A-related myotonia.

Epilepsia open
2024

Long-term prognosis of patients with photosensitive idiopathic generalized epilepsy.

Seizure
2024

Drug-resistant generalized epilepsies: Revisiting the frontiers of idiopathic generalized epilepsies.

Revue neurologique
2024

Clearance for Driving in Genetic Generalized Epilepsy.

Journal of child neurology
2024

Sarcopenia and anti-seizure medication response in juvenile myoclonic epilepsy.

Brain and behavior
2024

Drug-resistant juvenile myoclonic epilepsy: A literature review.

Revue neurologique
2024

Resting-state electroencephalography microstates as a marker of photosensitivity in juvenile myoclonic epilepsy.

Brain communications
2024

Whole exome sequencing identifies variable expressivity of CLN6 variants in Progressive myoclonic epilepsy affected families.

Epilepsy research
2024

Increased Thalamic Connectivity in Juvenile Myoclonic Epilepsy Based on Electroencephalography Source-Level Analysis.

Brain connectivity
2024

Diffusion tensor imaging in photosensitive and nonphotosensitive juvenile myoclonic epilepsy.

Seizure
2023

[Reflex triggers in juvenile myoclonic epilepsy].

Medicina
2023

Status epilepticus in patients with genetic generalized epilepsy: a case series study.

Acta epileptologica
2024

EFHC1 gene mutation profile of Turkish JME patients and its association with disease risk.

Seizure
2024

Lack of causal association between epilepsy and dementia: A Mendelian randomization analysis.

Epilepsy &amp; behavior : E&amp;B
2024

Exploring causal correlations between systemic inflammatory cytokines and epilepsy: A bidirectional Mendelian randomization study.

Seizure
2024

Adolescent-Onset Epilepsy: Clinical Features and Predictive Factors for First-Year Seizure Freedom.

Neuropediatrics
2024

Association of variants in the ABCB1, CYP2C19 and CYP2C9 genes for Juvenile Myoclonic Epilepsy.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2023

Differences in the distribution of triggers among resting state networks in patients with juvenile myoclonic epilepsy explained by network analysis.

Frontiers in neuroscience
2024

MRI-Based Radiomics Approach for Differentiating Juvenile Myoclonic Epilepsy from Epilepsy with Generalized Tonic-Clonic Seizures Alone.

Journal of magnetic resonance imaging : JMRI
2023

A comparison of comorbid headache between patients with temporal lobe epilepsy and juvenile myoclonic epilepsy.

Scientific reports
2023

Recognition and perception of emotions in juvenile myoclonic epilepsy.

Epilepsia
2023

Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy.

JAMA neurology
2023

SLCO5A1 and synaptic assembly genes contribute to impulsivity in juvenile myoclonic epilepsy.

NPJ genomic medicine
2023

[Idiopathic generalized epilepsies].

Medicina
2023

Gender differences in quality of life and psychiatric comorbidities among persons with juvenile myoclonic epilepsy: A single-center cross-sectional study.

Journal of neurosciences in rural practice
2024

Checkmate: Chess-induced reflex seizures in patient with juvenile myoclonic epilepsy.

Epileptic disorders : international epilepsy journal with videotape
2023

Seizure control with treatment of delayed sleep-wake phase disorder in juvenile myoclonic epilepsy: A case report.

Epilepsy &amp; behavior reports
2023

Cognitive phenotype of juvenile absence epilepsy: An investigation of patients and unaffected siblings.

Epilepsia
2023

Outcome of Absence Epilepsy With Onset at 8-11 Years of Age: Watershed Ages When Syndromes Overlap.

Journal of child neurology
2023

Outpatient visit behavior in patients with epilepsy: Generalized Epilepsy is more frequently non-attendance than Focal Epilepsy.

Epilepsy &amp; behavior : E&amp;B
2023

Multi-spectral diffusion MRI mega-analysis in genetic generalized epilepsy: Relation to outcomes.

NeuroImage. Clinical
2023

Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis.

Journal of neurology
2023

Facial Emotion Recognition in Patients with Juvenile Myoclonic Epilepsy.

Journal of clinical medicine
2023

Variation in prognosis and treatment outcome in juvenile myoclonic epilepsy: a Biology of Juvenile Myoclonic Epilepsy Consortium proposal for a practical definition and stratified medicine classifications.

Brain communications
2023

Two-year efficacy of lacosamide as adjunctive therapy for generalized tonic-clonic seizures in patients with juvenile myoclonic epilepsy.

Brain &amp; development
2023

Familial Adult Myoclonic Epilepsy: Clinical and Genetic Approach to an Under-recognized Disease.

Noro psikiyatri arsivi
2023

A cognitive rehabilitation program to improve hot and cool executive dysfunction in juvenile myoclonic epilepsy: Preliminary findings.

Epilepsy &amp; behavior : E&amp;B
2023

Structural insights of novel mutational frames in Bromodomain Containing-2 gene (BRD2) in juvenile myoclonic epilepsy: bed, bench, and laptop profiles.

Epilepsy &amp; behavior : E&amp;B
2023

Alzheimer Disease and Epilepsy: A Mendelian Randomization Study.

Neurology
2023

Neuropsychological profile and drug treatment response in Idiopathic Generalized Epilepsy.

Seizure
2023

Juvenile Myoclonic Epilepsy: Seizure and Social Outcomes in Taiwan.

Healthcare (Basel, Switzerland)
2023

Prevalence, nature, and severity of the psychiatric comorbidities and their impact on quality of life in adolescents with Juvenile myoclonic epilepsy.

Epilepsy &amp; behavior : E&amp;B
2022

Volume changes of medial temporal lobe structures in patients with genetic generalized and temporal lobe epilepsy in relation to neuropsychological functions.

Postepy psychiatrii neurologii
2023

Sub-region analysis of DMD gene in cases with idiopathic generalized epilepsy.

Neurogenetics
2023

Multilayer brain network modeling and dynamic analysis of juvenile myoclonic epilepsy.

Frontiers in behavioral neuroscience
2023

Clinical and electroencephalographic findings prior to the onset of juvenile myoclonic epilepsy: A case series.

Epileptic disorders : international epilepsy journal with videotape
2023

Myoclonic status epilepticus in patients with juvenile myoclonic epilepsy: Case reports and review of the literature.

Epileptic disorders : international epilepsy journal with videotape
2023

The role of additive and diffusive coupling on the dynamics of neural populations.

Scientific reports
2023

Dynamic flexibility and controllability of network communities in juvenile myoclonic epilepsy.

Neurobiology of disease
2024

Clinical application of trio-based whole-exome sequencing in idiopathic generalized epilepsy.

Seizure
2023

Differential diagnosis of familial adult myoclonic epilepsy.

Epilepsia
2023

Neurophysiology of Juvenile and Progressive Myoclonic Epilepsy.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
2023

Radiomic Models for Diagnosing Juvenile Myoclonic Epilepsy Should Note Its Genetic Heterogeneity.

Korean journal of radiology
2022

Diagnosis of comorbid migraine without aura in patients with idiopathic/genetic epilepsy based on the gray zone approach to the International Classification of Headache Disorders 3 criteria.

Frontiers in neurology
2022

Isolated Unilateral EEG Findings in Juvenile Myoclonic Epilepsy: A Case Report.

Journal of epilepsy research
2023

Paroxysmal Slow-Wave Events Are Uncommon in Parkinson's Disease.

Sensors (Basel, Switzerland)
2023

Cluster analysis of a large dataset of patients with juvenile myoclonic epilepsy: Predicting response to treatment.

Seizure
2023

Juvenile Myoclonic Epilepsy 25 Years After Seizure Onset: A Population-Based Study.

Neurology
2023

Prevalence of headache disorders in patients living with epilepsy in rural region in western part of India.

Epilepsy &amp; behavior : E&amp;B
2023

Abnormal gait and motor cortical processing in drug-resistant juvenile myoclonic epilepsy.

Brain and behavior
2022

Altered Cerebro-Cerebellar Effective Connectivity in New-Onset Juvenile Myoclonic Epilepsy.

Brain sciences
2022

Safety and Efficacy of Clonazepam in the Treatment of Juvenile Myoclonic Epilepsy: A Meta-Analysis.

Journal of pharmacy &amp; bioallied sciences
2022

Individualised prediction of drug resistance and seizure recurrence after medication withdrawal in people with juvenile myoclonic epilepsy: A systematic review and individual participant data meta-analysis.

EClinicalMedicine
2022

Development and Validation of MRI-Based Radiomics Models for Diagnosing Juvenile Myoclonic Epilepsy.

Korean journal of radiology
2023

Sleep quality and circadian rhythm profile of persons with juvenile myoclonic epilepsy in a tertiary epilepsy center: A case-control study.

Seizure
2022

Let's Talk About Sex and Juvenile Myoclonic Epilepsy.

Epilepsy currents
2022

Genetically proxied gut microbiota, gut metabolites with risk of epilepsy and the subtypes: A bi-directional Mendelian randomization study.

Frontiers in molecular neuroscience
2022

Causal relationship among obesity and body fat distribution and epilepsy subtypes.

Frontiers in neurology
2022

Executive functions and personality traits of juvenile myoclonic epilepsy patients: a single-center experience of 23 cases.

Turkish journal of medical sciences
2022

The spectrum of epilepsy with eyelid myoclonia: delineation of disease subtypes from a large multicenter study.

Epilepsia
2022

EEG Markers of Treatment Resistance in Idiopathic Generalized Epilepsy: From Standard EEG Findings to Advanced Signal Analysis.

Biomedicines
2022

A Case of a Seven-Year-old boy with Epilepsy with Myoclonic Absence: Importance of Seizure Semiology, Genetic Etiology, and Electroencephalogram Correlation for Timely Intervention.

Child neurology open
2023

A healthy outcome of a pregnant woman with drug-resistant juvenile myoclonic epilepsy treated with brivaracetam.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022

Hyperperfusion in the cerebellum lobule VIIb in patients with epileptic seizures.

BMC neurology
2022

Drug resistance in idiopathic generalized epilepsies: Evidence and concepts.

Epilepsia
2023

Idiopathic generalized epilepsies: Analysis of 101 patients.

Medicina clinica
2022

Efficacy of levetiracetam, lamotrigine and sodium valproate on seizure attacks and EEG disorders in patients with juvenile myoclonic epilepsy: A double blind randomized clinical trial.

Caspian journal of internal medicine
2022

Altered dynamic functional connectivity of striatal-cortical circuits in Juvenile Myoclonic Epilepsy.

Seizure
2022

Understanding frontal lobe function in epilepsy: Juvenile myoclonic epilepsy vs. frontal lobe epilepsy.

Epilepsy &amp; behavior : E&amp;B
2022

Heterogeneity of resting-state EEG features in juvenile myoclonic epilepsy and controls.

Brain communications
2022

[Optimal Use of Perampanel in the Treatment of Patients with Epilepsy Based on the Clinical Evidence and Characteristics].

Brain and nerve = Shinkei kenkyu no shinpo
2022

Characterization of cortical activity in juvenile myoclonic epilepsy by gradient magnetic field topography.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2022

[Structural changes to the brain in drug-resistant juvenile myoclonic epilepsy].

Revista de neurologia
2022

Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study.

Seizure
2022

Distributed source localization of epileptiform discharges in juvenile myoclonic epilepsy: Standardized low-resolution brain electromagnetic tomography (sLORETA) Study.

Medicine
2022

Omitting Hyperventilation in Electroencephalogram during the COVID-19 Pandemic May Reduce Interictal Epileptiform Discharges in Patients with Juvenile Myoclonic Epilepsy.

Brain sciences
2022

Emotional Word Processing in Patients With Juvenile Myoclonic Epilepsy.

Frontiers in neurology
2022

Childhood absence epilepsy: Electro-clinical manifestations, treatment options, and outcome in a tertiary educational center.

International journal of pediatrics &amp; adolescent medicine
2022

Correlations Between Structural Brain Abnormalities, Cognition and Electroclinical Characteristics in Patients With Juvenile Myoclonic Epilepsy.

Frontiers in neurology
2022

Can Disruption of Basal Ganglia-Thalamocortical Circuit in Wilson Disease Be Associated with Juvenile Myoclonic Epilepsy Phenotype?

Brain sciences
2022

School performance and psychiatric comorbidity in juvenile absence epilepsy and juvenile myoclonic epilepsy: a Danish population-based cohort study.

Journal of neurology
2022

Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020.

Seizure
2022

ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions.

Epilepsia
2022

The Local Topological Reconfiguration in the Brain Network After Targeted Hub Dysfunction Attacks in Patients With Juvenile Myoclonic Epilepsy.

Frontiers in neuroscience
Ver todos os 773 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Epilepsia mioclônica juvenil.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Epilepsia mioclônica juvenil

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Investigation of adolescent cases diagnosed with idiopathic/genetic generalized epilepsy in terms of self-esteem, aggression, body perception, and alexithymia.
    European journal of pediatrics· 2026· PMID 41857384mais citado
  2. Transcriptional and neurotransmitter signatures associated with regional gray matter alterations in juvenile myoclonic epilepsy.
    Frontiers in molecular neuroscience· 2026· PMID 41696713mais citado
  3. Exploring Balance and Functional Mobility in Children with Juvenile Myoclonic Epilepsy, Effects of Cognitive and Motor Dual-Tasks: An Exploratory Pilot Study.
    Physical &amp; occupational therapy in pediatrics· 2026· PMID 40948457mais citado
  4. Effects of lipid-lowering drugs on epilepsy and its subtypes: A drug-target Mendelian randomization study.
    Medicine· 2026· PMID 41861198mais citado
  5. Sleep disorders in patients with juvenile myoclonic epilepsy: A polysomnographic investigation.
    Epilepsy research· 2026· PMID 41702318mais citado
  6. Thermodynamic rigidity of harmonic brain states relates to general mental ability in juvenile myoclonic epilepsy.
    bioRxiv· 2026· PMID 41993553recente
  7. The network neuropsychology of neighborhood deprivation in juvenile myoclonic epilepsy.
    Sci Rep· 2026· PMID 41991596recente
  8. Leukocytes Transcriptome Analysis of Genes Associated with Epilepsy Duration and Age of Onset.
    Mol Neurobiol· 2026· PMID 41949661recente
  9. Juvenile myoclonic epilepsy heterogeneity uncovered: Z-mapped imaging endophenotypes of cortical and subcortical structures and their clinical, cognitive and psychiatric features.
    Brain Commun· 2026· PMID 41930256recente
  10. Coexistence of Mesial Temporal Sclerosis and Juvenile Myoclonic Epilepsy.
    Prim Care Companion CNS Disord· 2026· PMID 41894667recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:307(Orphanet)
  2. OMIM OMIM:254770(OMIM)
  3. MONDO:0009696(MONDO)
  4. Epilepsia(PCDT · Ministério da Saúde)
  5. GARD:6808(GARD (NIH))
  6. Variantes catalogadas(ClinVar)
  7. Busca completa no PubMed(PubMed)
  8. Q543517(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Epilepsia mioclônica juvenil
Compêndio · Raras BR

Epilepsia mioclônica juvenil

ORPHA:307 · MONDO:0009696
🇧🇷 Brasil SUS
Geral
Prevalência
Unknown
Herança
Multigenic/multifactorial
CID-10
G40.3 · Epilepsia e síndromes epilépticas generalizadas idiopáticas
CID-11
Ensaios
1 ativos
Início
Adolescent, Childhood
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0270853
Repurposing
14 candidatos
aminohydroxybutyric-acidcarbonic anhydrase inhibitor
diclofenamidesuccinimide antiepileptic
ethosuximideglutamate receptor antagonist
+11 outros
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades